Replimune Group (REPL)
(Delayed Data from NSDQ)
$9.86 USD
+0.13 (1.34%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $9.85 -0.01 (-0.10%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Balance Sheet
Fiscal Year End for Replimune Group, Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 421 | 583 | 396 | 476 | 169 |
Receivables | 5 | 3 | 3 | 3 | 3 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 8 | 6 | 5 | 4 | 3 |
Total Current Assets | 434 | 593 | 404 | 484 | 174 |
Net Property & Equipment | 10 | 7 | 8 | 7 | 7 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 2 | 2 | 2 | 2 | 2 |
Total Assets | 488 | 647 | 461 | 543 | 234 |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 5 | 4 | 2 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 3 | 3 | 3 | 2 | 2 |
Accrued Expenses | 34 | 25 | 13 | 9 | 5 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 40 | 34 | 21 | 15 | 12 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 45 | 29 | 0 | 0 | 10 |
Non-Current Capital Leases | 23 | 24 | 24 | 25 | 25 |
Other Non-Current Liabilities | 1 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 113 | 91 | 50 | 44 | 50 |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,071 | 1,035 | 723 | 692 | 297 |
Retained Earnings | -701 | -485 | -311 | -193 | -112 |
Other Equity | 5 | 6 | -1 | 0 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 375 | 555 | 411 | 499 | 184 |
Total Liabilities & Shareholder's Equity | 488 | 647 | 461 | 543 | 234 |
Total Common Equity | 375 | 555 | 411 | 499 | 184 |
Shares Outstanding | 61.39 | 56.66 | 47.20 | 46.40 | 36.60 |
Book Value Per Share | 6.10 | 9.80 | 8.71 | 10.75 | 5.02 |
Fiscal Year End for Replimune Group, Inc falls in the month of March.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 469 | 421 | 466 | 497 | 539 |
Receivables | 5 | 5 | 4 | 3 | 3 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | 6 | 8 | 9 | 9 | 8 |
Total Current Assets | 480 | 434 | 479 | 508 | 550 |
Net Property & Equipment | 11 | 10 | 9 | 8 | 8 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 1 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 2 | 2 | 2 | 2 | 2 |
Total Assets | 535 | 488 | 533 | 562 | 604 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 3 | 4 | 4 | 5 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 3 | 3 | 3 | 3 | 3 |
Accrued Expenses | 31 | 34 | 31 | 32 | 24 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | 36 | 40 | 39 | 40 | 32 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | 45 | 45 | 44 | 29 | 29 |
Non-Current Capital Leases | 23 | 23 | 24 | 24 | 24 |
Other Non-Current Liabilities | 1 | 1 | 0 | 1 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | 109 | 113 | 111 | 97 | 90 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,177 | 1,071 | 1,063 | 1,055 | 1,045 |
Retained Earnings | -755 | -701 | -646 | -595 | -535 |
Other Equity | 4 | 5 | 5 | 5 | 4 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 426 | 375 | 422 | 465 | 514 |
Total Liabilities & Shareholder's Equity | 535 | 488 | 533 | 562 | 604 |
Total Common Equity | 100,425 | 375 | 422 | 465 | 514 |
Shares Outstanding | 68.32 | 61.39 | 59.00 | 59.00 | 59.00 |
Book Value Per Share | 1,469.93 | 6.10 | 7.14 | 7.88 | 8.71 |